Tim Andrews, 67, is still alive and is back on the waiting list for a human donor. However, the success of his highly experimental procedure means more patients are scheduled to get genetically modified animal organs.
A new study published in JAMA, which looked at fee-for-service Medicare records from 2013–2023, found that overall participation has trended upward. However, the details paint a complicated picture.
Research that followed patients for more than 13 years suggests increases in ECG PR interval, P‐wave duration and PTFV1 are associated with increased AFib risk in this cohort.
The Cardiovascular Research Foundation (CRF) announced the 32 late-breaking studies being presented at the Transcatheter Cardiovascular Therapeutics 2022 annual meeting at in Boston, Sept. 16-19.
Briefly trained in point-of-care cardiac ultrasound, 72% of second-year medical students obtained clinical-quality views from a mannequin and 61% made the correct diagnosis in a volunteer simulated patient.
Orthopedic cone-beam CT supplier CurveBeam AI has received the FDA’s breakthrough device designation for software that computes risk of fracture in patients with osteopenia.
Nuclear radiologists are overall confident in the scientific soundness of studies published within their field. Those working in Asia are especially trusting. However ...
The FDA has approved a clinical trial to evaluate the safety and efficacy of a new type of ablation catheter for patients with ventricular tachycardia (VT) resistant to conventional anti-arrhythmic drugs or standard ablation procedures.
“Results of this case-control study suggest that even for maximum univariate biological differences, deviations between patients with MDD and healthy controls were remarkably small," experts shared in JAMA Psychiatry.
A new analysis offers a detailed comparison of soft-tissue lymphomas and soft-tissue tumors based on imaging characteristics from MRI scans—an area of study that has not yet been rigorously explored, the authors of the paper indicated.
